Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, manufacture, and marketing of pharmaceutical products in Spain and internationally. The company provides products for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas. Its principal products include Ameride, Bertanel, Bluxam, Enoxaparin Rovi, Calcium Vitamine D3 Rovi, Exxiv, Prinvil, Rhodogil, Glufan, Hibor, Hirobriz Breezhaler, Neparvis, Medicebran, Medikinet, Mysimba, Orvatez, Tryptizol, Ulunar Breezhaler, and Volutsa; and hospital products, such as Iomeron and Iopamiro, Multihance and Y Prohance, Sonovue, Empowercta+, Empowermr, and CT Express, Fibrilin, and Sodium Heparin Rovi. It also provides contract-manufacturing services to other companies for a range of pharmaceutical forms, including prefilled syringes, vials, suppositories, tablets, and sachets. Laboratorios Farmaceuticos Rovi, S.A. was incorporated in 1946 and is headquartered in Madrid, Spain. Laboratorios Farmaceúticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L.
| 90.61 | |
| 90.61 | |
| - | |
| 90.61 | |
| 90.61 | |
| 49.5983-90.61 | |
| 4 882 M | |
| 32.2456 | |
| 51 149 K | |
| 779 M | |
| 0.0132 | |
| 0.51 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Moderna (MRNA) is ramping up its investments in production capacity to more than triple its annual COVID-19 vaccine output for 2022, paving the way for more messenger RNA COVID-19 vaccines to be in ci...
Moderna (MRNA) is ramping up its investments in production capacity to more than triple its annual COVID-19 vaccine output for 2022, paving the way for more messenger RNA COVID-19 vaccines to be in ci...
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
